Related Experiment Videos
Radiation therapy tolerance limits. For one or for all?--Janeway Lecture
1Division of Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston, USA.
Cancer
|June 1, 1996
Summary
Predicting individual patient radiation tolerance is key to optimizing cancer therapy. Current fibroblast radiosensitivity assays show promise but need improvement for clinical use, aiming for personalized treatment to tolerance.
Area of Science:
- Radiation oncology
- Medical physics
- Cell biology
Background:
- Radiation therapy optimal use is limited by population-based normal tissue tolerance limits.
- Individual patient susceptibility to radiation sequelae varies significantly.
- Predictive assays for normal tissue tolerance are needed for personalized treatment.
Purpose of the Study:
- To test if normal skin fibroblast radiosensitivity predicts late connective tissue damage after radiotherapy.
- To review radiation reaction pathogenesis and cellular senescence role in late effects.
Main Methods:
- Laboratory research summarizing studies on fibroblast radiosensitivity.
- Review of radiation pathogenesis and cellular senescence.
Main Results:
- Clinical studies show correlation between fibroblast radiosensitivity and late radiation sequelae.
- Current fibroblast cell survival assays lack clinical precision and reproducibility.
- Newer assays using cellular senescence and cytokine production are under development.
Conclusions:
- The principle of predicting radiotherapy tolerance is established.
- Current assays require further development for clinical application.
- Individualized treatment to tolerance is the ultimate goal.